TY - JOUR T1 - Cost effectiveness of interventions for Post-Traumatic Stress Disorders following major incidents including terrorism and pandemics JF - medRxiv DO - 10.1101/2020.06.26.20141051 SP - 2020.06.26.20141051 AU - Nicole Hogan AU - Martin Knapp AU - David McDaid AU - Mark Davies AU - Chris R. Brewin Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/12/2020.06.26.20141051.abstract N2 - Background Post-traumatic stress disorder (PTSD) is commonly experienced in the aftermath of major incidents such as terrorism and pandemics. Well-established principles of response include effective and scalable treatment for individuals affected by PTSD. In England, such responses have combined proactive outreach, screening, and evidence-based interventions (a “screen-and-treat” approach), but little is known about the cost-effectiveness of this approach.Methods A decision modelling analysis was undertaken to estimate the costs per quality adjusted life year (QALY) gained from a screen-and-treat approach compared to treatment-as-usual. Model input variables were drawn from relevant empirical studies in the context of terrorism and the unit costs of health and social care in England. The model was run over a five-year time horizon for a hypothetical cohort of 1,000 exposed adults from the perspective of the National Health Service and Personal Social Services in England.Results The incremental cost per QALY gained was £8,297. This would be considered cost-effective 95% of the time at a willingness-to-pay threshold of £20,000 per QALY gained, the threshold associated with NICE. Sensitivity analysis confirmed this result was robust.Conclusions A screen-and-treat approach for identifying and treating PTSD in adults following major incidents appears cost-effective in England compared to treatment-as-usual through conventional primary care routes. This finding was in the context of terrorism but can be translatable into other major-incident related scenarios including the current COVID-19 pandemic in lieu of data on the impact of this pandemic.Competing interest statement The authors have declared no competing interest.Funding statement No additional funding was provided for this studyAuthor Declarations All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCompeting Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this article. All time and resources were underwritten by the authors themselves.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll economic data analysis can be provided on request to the uploading author ER -